Review



rabbit anti cd16 2 fcgr4 fc antibody  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Novus Biologicals rabbit anti cd16 2 fcgr4 fc antibody
    primary and superimposed infection induce different patterns of macrophage activation. (A) Indirect immunofluorescence with recombinant <t>anti-CD16-2/FCGR4/Fc</t> for M1 and antibody MR/CD206/Mannose Receptor for M2 (red) on intestinal tissue of Institute of Cancer Research (ICR) naïve and mice after Echinostoma caproni primary, superimposed infection in mice and superimposed infections in anti-interleuquin-25 (α-IL-25)-treated mice (scale bar: 100 mm). (B) Quantitation of the percentage of area covered by anti-CD16-2/FCGR4/Fc for M1 and antibody MR/CD206/Mannose Receptor staining. Vertical bars show standard deviation. a: significant differences with respect to negative controls; b: significant differences with respect to primary infections; c: significant differences with respect to superimposed infection- in α-IL-25-treated mice (p < 0.05).
    Rabbit Anti Cd16 2 Fcgr4 Fc Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+cd16+2+fcgr4+fc+antibody/FcgR4%2FCD16-2+Antibody+(012)/pmc12543364-61-1-15
    Average 93 stars, based on 1 article reviews
    rabbit anti cd16 2 fcgr4 fc antibody - by Bioz Stars, 2026-10
    93/100 stars

    Images

    1) Product Images from "Concomitant immunity against superimposed homologous Echinostoma caproni infections in mice is mediated by interleuquin-25"

    Article Title: Concomitant immunity against superimposed homologous Echinostoma caproni infections in mice is mediated by interleuquin-25

    Journal: Memórias do Instituto Oswaldo Cruz

    doi: 10.1590/0074-02760250004

    primary and superimposed infection induce different patterns of macrophage activation. (A) Indirect immunofluorescence with recombinant anti-CD16-2/FCGR4/Fc for M1 and antibody MR/CD206/Mannose Receptor for M2 (red) on intestinal tissue of Institute of Cancer Research (ICR) naïve and mice after Echinostoma caproni primary, superimposed infection in mice and superimposed infections in anti-interleuquin-25 (α-IL-25)-treated mice (scale bar: 100 mm). (B) Quantitation of the percentage of area covered by anti-CD16-2/FCGR4/Fc for M1 and antibody MR/CD206/Mannose Receptor staining. Vertical bars show standard deviation. a: significant differences with respect to negative controls; b: significant differences with respect to primary infections; c: significant differences with respect to superimposed infection- in α-IL-25-treated mice (p < 0.05).
    Figure Legend Snippet: primary and superimposed infection induce different patterns of macrophage activation. (A) Indirect immunofluorescence with recombinant anti-CD16-2/FCGR4/Fc for M1 and antibody MR/CD206/Mannose Receptor for M2 (red) on intestinal tissue of Institute of Cancer Research (ICR) naïve and mice after Echinostoma caproni primary, superimposed infection in mice and superimposed infections in anti-interleuquin-25 (α-IL-25)-treated mice (scale bar: 100 mm). (B) Quantitation of the percentage of area covered by anti-CD16-2/FCGR4/Fc for M1 and antibody MR/CD206/Mannose Receptor staining. Vertical bars show standard deviation. a: significant differences with respect to negative controls; b: significant differences with respect to primary infections; c: significant differences with respect to superimposed infection- in α-IL-25-treated mice (p < 0.05).

    Techniques Used: Infection, Activation Assay, Immunofluorescence, Recombinant, Quantitation Assay, Staining, Standard Deviation

    Related Articles

    Infection:

    Article Title: Concomitant immunity against superimposed homologous Echinostoma caproni infections in mice is mediated by interleuquin-25
    Article Snippet: The slides were incubated at 4oC overnight in a humid chamber with the primary antibody.The slides were incubated at 4oC overnight in a humid chamber with the primary antibody.. A rabbit anti-CD16-2/FCGR4/Fc antibody (Sino Biological, clone no. 012), and a goat antibody MR/CD206/Mannose Receptor (Novus Invitro Technologies Ltd, Colorado, USA) were used for labelling M1 and M2, respectively.. Both antibodies were diluted in 1% BSA-PBS-0.2% Triton X-100 (1:100 for M1 and 1:200 for M2).Both antibodies were diluted in 1% BSA-PBS-0.2% Triton X-100 (1:100 for M1 and 1:200 for M2).

    Activation Assay:

    Article Title: Concomitant immunity against superimposed homologous Echinostoma caproni infections in mice is mediated by interleuquin-25
    Article Snippet: The slides were incubated at 4oC overnight in a humid chamber with the primary antibody.The slides were incubated at 4oC overnight in a humid chamber with the primary antibody.. A rabbit anti-CD16-2/FCGR4/Fc antibody (Sino Biological, clone no. 012), and a goat antibody MR/CD206/Mannose Receptor (Novus Invitro Technologies Ltd, Colorado, USA) were used for labelling M1 and M2, respectively.. Both antibodies were diluted in 1% BSA-PBS-0.2% Triton X-100 (1:100 for M1 and 1:200 for M2).Both antibodies were diluted in 1% BSA-PBS-0.2% Triton X-100 (1:100 for M1 and 1:200 for M2).

    Immunofluorescence:

    Article Title: Concomitant immunity against superimposed homologous Echinostoma caproni infections in mice is mediated by interleuquin-25
    Article Snippet: The slides were incubated at 4oC overnight in a humid chamber with the primary antibody.The slides were incubated at 4oC overnight in a humid chamber with the primary antibody.. A rabbit anti-CD16-2/FCGR4/Fc antibody (Sino Biological, clone no. 012), and a goat antibody MR/CD206/Mannose Receptor (Novus Invitro Technologies Ltd, Colorado, USA) were used for labelling M1 and M2, respectively.. Both antibodies were diluted in 1% BSA-PBS-0.2% Triton X-100 (1:100 for M1 and 1:200 for M2).Both antibodies were diluted in 1% BSA-PBS-0.2% Triton X-100 (1:100 for M1 and 1:200 for M2).

    Recombinant:

    Article Title: Concomitant immunity against superimposed homologous Echinostoma caproni infections in mice is mediated by interleuquin-25
    Article Snippet: The slides were incubated at 4oC overnight in a humid chamber with the primary antibody.The slides were incubated at 4oC overnight in a humid chamber with the primary antibody.. A rabbit anti-CD16-2/FCGR4/Fc antibody (Sino Biological, clone no. 012), and a goat antibody MR/CD206/Mannose Receptor (Novus Invitro Technologies Ltd, Colorado, USA) were used for labelling M1 and M2, respectively.. Both antibodies were diluted in 1% BSA-PBS-0.2% Triton X-100 (1:100 for M1 and 1:200 for M2).Both antibodies were diluted in 1% BSA-PBS-0.2% Triton X-100 (1:100 for M1 and 1:200 for M2).

    Quantitation Assay:

    Article Title: Concomitant immunity against superimposed homologous Echinostoma caproni infections in mice is mediated by interleuquin-25
    Article Snippet: The slides were incubated at 4oC overnight in a humid chamber with the primary antibody.The slides were incubated at 4oC overnight in a humid chamber with the primary antibody.. A rabbit anti-CD16-2/FCGR4/Fc antibody (Sino Biological, clone no. 012), and a goat antibody MR/CD206/Mannose Receptor (Novus Invitro Technologies Ltd, Colorado, USA) were used for labelling M1 and M2, respectively.. Both antibodies were diluted in 1% BSA-PBS-0.2% Triton X-100 (1:100 for M1 and 1:200 for M2).Both antibodies were diluted in 1% BSA-PBS-0.2% Triton X-100 (1:100 for M1 and 1:200 for M2).

    Staining:

    Article Title: Concomitant immunity against superimposed homologous Echinostoma caproni infections in mice is mediated by interleuquin-25
    Article Snippet: The slides were incubated at 4oC overnight in a humid chamber with the primary antibody.The slides were incubated at 4oC overnight in a humid chamber with the primary antibody.. A rabbit anti-CD16-2/FCGR4/Fc antibody (Sino Biological, clone no. 012), and a goat antibody MR/CD206/Mannose Receptor (Novus Invitro Technologies Ltd, Colorado, USA) were used for labelling M1 and M2, respectively.. Both antibodies were diluted in 1% BSA-PBS-0.2% Triton X-100 (1:100 for M1 and 1:200 for M2).Both antibodies were diluted in 1% BSA-PBS-0.2% Triton X-100 (1:100 for M1 and 1:200 for M2).

    Standard Deviation:

    Article Title: Concomitant immunity against superimposed homologous Echinostoma caproni infections in mice is mediated by interleuquin-25
    Article Snippet: The slides were incubated at 4oC overnight in a humid chamber with the primary antibody.The slides were incubated at 4oC overnight in a humid chamber with the primary antibody.. A rabbit anti-CD16-2/FCGR4/Fc antibody (Sino Biological, clone no. 012), and a goat antibody MR/CD206/Mannose Receptor (Novus Invitro Technologies Ltd, Colorado, USA) were used for labelling M1 and M2, respectively.. Both antibodies were diluted in 1% BSA-PBS-0.2% Triton X-100 (1:100 for M1 and 1:200 for M2).Both antibodies were diluted in 1% BSA-PBS-0.2% Triton X-100 (1:100 for M1 and 1:200 for M2).



    Similar Products

    rabbit anti cd16 2 fcgr4 fc antibody  (Sino Biological)
    90
    Sino Biological rabbit anti cd16 2 fcgr4 fc antibody
    primary and superimposed infection induce different patterns of macrophage activation. (A) Indirect immunofluorescence with recombinant <t>anti-CD16-2/FCGR4/Fc</t> for M1 and antibody MR/CD206/Mannose Receptor for M2 (red) on intestinal tissue of Institute of Cancer Research (ICR) naïve and mice after Echinostoma caproni primary, superimposed infection in mice and superimposed infections in anti-interleuquin-25 (α-IL-25)-treated mice (scale bar: 100 mm). (B) Quantitation of the percentage of area covered by anti-CD16-2/FCGR4/Fc for M1 and antibody MR/CD206/Mannose Receptor staining. Vertical bars show standard deviation. a: significant differences with respect to negative controls; b: significant differences with respect to primary infections; c: significant differences with respect to superimposed infection- in α-IL-25-treated mice (p < 0.05).
    Rabbit Anti Cd16 2 Fcgr4 Fc Antibody, supplied by Sino Biological, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+cd16+2+fcgr4+fc+antibody/CD16-2+FCGR4+Antibody%2C+Rabbit+MAb/pmc12543364-61-1-4
    Average 90 stars, based on 1 article reviews
    rabbit anti cd16 2 fcgr4 fc antibody - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    rabbit anti cd16 2 fcgr4 fc antibody  (Novus Biologicals)
    93
    Novus Biologicals rabbit anti cd16 2 fcgr4 fc antibody
    primary and superimposed infection induce different patterns of macrophage activation. (A) Indirect immunofluorescence with recombinant <t>anti-CD16-2/FCGR4/Fc</t> for M1 and antibody MR/CD206/Mannose Receptor for M2 (red) on intestinal tissue of Institute of Cancer Research (ICR) naïve and mice after Echinostoma caproni primary, superimposed infection in mice and superimposed infections in anti-interleuquin-25 (α-IL-25)-treated mice (scale bar: 100 mm). (B) Quantitation of the percentage of area covered by anti-CD16-2/FCGR4/Fc for M1 and antibody MR/CD206/Mannose Receptor staining. Vertical bars show standard deviation. a: significant differences with respect to negative controls; b: significant differences with respect to primary infections; c: significant differences with respect to superimposed infection- in α-IL-25-treated mice (p < 0.05).
    Rabbit Anti Cd16 2 Fcgr4 Fc Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+cd16+2+fcgr4+fc+antibody/FcgR4%2FCD16-2+Antibody+(012)/pmc12543364-61-1-15
    Average 93 stars, based on 1 article reviews
    rabbit anti cd16 2 fcgr4 fc antibody - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    primary and superimposed infection induce different patterns of macrophage activation. (A) Indirect immunofluorescence with recombinant anti-CD16-2/FCGR4/Fc for M1 and antibody MR/CD206/Mannose Receptor for M2 (red) on intestinal tissue of Institute of Cancer Research (ICR) naïve and mice after Echinostoma caproni primary, superimposed infection in mice and superimposed infections in anti-interleuquin-25 (α-IL-25)-treated mice (scale bar: 100 mm). (B) Quantitation of the percentage of area covered by anti-CD16-2/FCGR4/Fc for M1 and antibody MR/CD206/Mannose Receptor staining. Vertical bars show standard deviation. a: significant differences with respect to negative controls; b: significant differences with respect to primary infections; c: significant differences with respect to superimposed infection- in α-IL-25-treated mice (p < 0.05).

    Journal: Memórias do Instituto Oswaldo Cruz

    Article Title: Concomitant immunity against superimposed homologous Echinostoma caproni infections in mice is mediated by interleuquin-25

    doi: 10.1590/0074-02760250004

    Figure Lengend Snippet: primary and superimposed infection induce different patterns of macrophage activation. (A) Indirect immunofluorescence with recombinant anti-CD16-2/FCGR4/Fc for M1 and antibody MR/CD206/Mannose Receptor for M2 (red) on intestinal tissue of Institute of Cancer Research (ICR) naïve and mice after Echinostoma caproni primary, superimposed infection in mice and superimposed infections in anti-interleuquin-25 (α-IL-25)-treated mice (scale bar: 100 mm). (B) Quantitation of the percentage of area covered by anti-CD16-2/FCGR4/Fc for M1 and antibody MR/CD206/Mannose Receptor staining. Vertical bars show standard deviation. a: significant differences with respect to negative controls; b: significant differences with respect to primary infections; c: significant differences with respect to superimposed infection- in α-IL-25-treated mice (p < 0.05).

    Article Snippet: A rabbit anti-CD16-2/FCGR4/Fc antibody (Sino Biological, clone no. 012), and a goat antibody MR/CD206/Mannose Receptor (Novus Invitro Technologies Ltd, Colorado, USA) were used for labelling M1 and M2, respectively.

    Techniques: Infection, Activation Assay, Immunofluorescence, Recombinant, Quantitation Assay, Staining, Standard Deviation

    primary and superimposed infection induce different patterns of macrophage activation. (A) Indirect immunofluorescence with recombinant anti-CD16-2/FCGR4/Fc for M1 and antibody MR/CD206/Mannose Receptor for M2 (red) on intestinal tissue of Institute of Cancer Research (ICR) naïve and mice after Echinostoma caproni primary, superimposed infection in mice and superimposed infections in anti-interleuquin-25 (α-IL-25)-treated mice (scale bar: 100 mm). (B) Quantitation of the percentage of area covered by anti-CD16-2/FCGR4/Fc for M1 and antibody MR/CD206/Mannose Receptor staining. Vertical bars show standard deviation. a: significant differences with respect to negative controls; b: significant differences with respect to primary infections; c: significant differences with respect to superimposed infection- in α-IL-25-treated mice (p < 0.05).

    Journal: Memórias do Instituto Oswaldo Cruz

    Article Title: Concomitant immunity against superimposed homologous Echinostoma caproni infections in mice is mediated by interleuquin-25

    doi: 10.1590/0074-02760250004

    Figure Lengend Snippet: primary and superimposed infection induce different patterns of macrophage activation. (A) Indirect immunofluorescence with recombinant anti-CD16-2/FCGR4/Fc for M1 and antibody MR/CD206/Mannose Receptor for M2 (red) on intestinal tissue of Institute of Cancer Research (ICR) naïve and mice after Echinostoma caproni primary, superimposed infection in mice and superimposed infections in anti-interleuquin-25 (α-IL-25)-treated mice (scale bar: 100 mm). (B) Quantitation of the percentage of area covered by anti-CD16-2/FCGR4/Fc for M1 and antibody MR/CD206/Mannose Receptor staining. Vertical bars show standard deviation. a: significant differences with respect to negative controls; b: significant differences with respect to primary infections; c: significant differences with respect to superimposed infection- in α-IL-25-treated mice (p < 0.05).

    Article Snippet: A rabbit anti-CD16-2/FCGR4/Fc antibody (Sino Biological, clone no. 012), and a goat antibody MR/CD206/Mannose Receptor (Novus Invitro Technologies Ltd, Colorado, USA) were used for labelling M1 and M2, respectively.

    Techniques: Infection, Activation Assay, Immunofluorescence, Recombinant, Quantitation Assay, Staining, Standard Deviation